Dr Jessamy Tiffen

Group Leader, Melanoma Epigenetics Laboratory, The Centenary Institute. Head of Centre for Cancer Innovations, The Centenary Institute

[Roychoudhuri Lab @RoychoudhuriLab]

Thrilled to share new work led by @JieYang437 in the lab published today in @Nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. @Cambridge_Uni @CRUKCamCentre https://t.co/dO2v0GWKAn

[Dr Jessamy Tiffen @JessTiffen]

@hfjbrtedfhkh mg z
Nmvbhhh

[Dr Jessamy Tiffen @JessTiffen]

Deeply concerned for my US collaborators……

[nature @Nature]

In an unprecedented move, research-grant reviews have been suspended indefinitely at the world’s largest public funder of biomedical research

https://t.co/rEmlD6lFgE

[Ziyad Al-Aly, MD @zalaly]

1. What are the benefits and risks of GLP1?

Our new study in @naturemedicine comprehensively maps all the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound).

By @Biostayan, Taeyoung Choi and me
🧵

https://t.co/cJR8t1fZU8

[Simona Cristea @simocristea]

Cancer statistics in 2025 🇺🇸- new report 🚨

Cancer is becoming a new disease.

We're seeing a fundamental shift in who gets cancer, moving from a predominantly male, elderly disease to one that increasingly affects women and younger people.

Key highlights 🧵

[Dr Jessamy Tiffen @JessTiffen]

Super fun BBQ and swim at my house for past and present lab members and their families. Stephen and Alice are about to graduate with their MDs. Great science is so much more about the people than experiments. @DrHYTseng @CentenaryInst

[Dr Jessamy Tiffen @JessTiffen]

SEX! Now that I have your attention, check out our review on these fascinating yet under appreciated chromosomes with roles in cancer survival outcomes. https://t.co/rJk3SyQ2z7

[Dr Jessamy Tiffen @JessTiffen]

Looks like it’s back to the ARC grants. #AcademicTwitter

[Kameron Mazurek @KameronMazurek]

According to NBC, “Raygun” has a PhD in cultural studies and teaches about breaking, hip-hop culture, and gender studies related to these specific dances.

This is Napoleon Dynamite level stuff.

[Dr Jessamy Tiffen @JessTiffen]

Super grateful to the AMRF for supporting Laura’s project on an epigenetic switch for undifferentiated melanoma.

[Centenary Institute @CentenaryInst]

Congratulations to Dr @JessTiffen & master’s student Laura Nicholls, who have been awarded a $10,000 research grant from @MelanomaAU . The grant will support Laura’s study into a resilient type of melanoma that often evades current treatments. More: https://t.co/mBZHkH0YVE

[Samuel Hume @DrSamuelBHume]

The 10 biggest cancer papers of the last 10 years (in my opinion)

1. Blocking PD1 activates the immune response against cancer - especially if the cancer has more mutations

https://t.co/rBCVRcDfvo

[Centenary Institute @CentenaryInst]

You're invited to our FREE interactive online event Skin Deep: understanding melanoma. For more information and to register go to: https://t.co/5FY3DPp0F1
#centenaryinstitute #melanoma #medicalresearch #medicalwebinar

[A/Prof Michelle McDonald @michbal19]

I am looking for a post doc to join my new lab ⁦@Sydney_Uni⁩! This is a great opportunity for an ECR to work with my team using cutting edge imaging approaches 🔬 to dive into bone metastatic breast cancer … and enjoy the Sydney life ☀️ 🏖️🤗 https://t.co/7iY4X6DYOm

[Dr Jessamy Tiffen @JessTiffen]

Jennifer Doudna at the Sydney Opera House with my favourite neuroscientist. @DrEleanorD

[Dr Jessamy Tiffen @JessTiffen]

@lab_marine @DrHYTseng @emran_geb Thanks Chris. I know it well! Your discussion points helped us get it over the line. We don’t have much mechanism but the innate and adaptive resistance mouse models are solid if you’d ever like to discuss.

[Dr Jessamy Tiffen @JessTiffen]

More great work from my team on epigenetic BET inhibitors.
Here we show they combine well with antiCTLA-4 immune checkpoint inhibition (ICI) to combat melanoma with innate resistance to antiPD-1/L1 (frontline) ICI in a mouse model.
@DrHYTseng @emran_geb
https://t.co/FhEvXXg3Gz

[Dr Jessamy Tiffen @JessTiffen]

This is remarkable. Cancer in the complete absence of a single genetic mutation. Another win for team epigentics! https://t.co/nrwbk3wAyw

[Dr Jessamy Tiffen @JessTiffen]

@TheStarkLab @nhmrc @UQMedicine @AusSSC @TRI_info Amazing Mitch! Well deserved my friend

[Dr Jessamy Tiffen @JessTiffen]

Like Catherine, more under-50s are being diagnosed with cancer https://t.co/zWATNZ4IKc

[Dr Jessamy Tiffen @JessTiffen]

Estimating cancers attributable to physical inactivity in Australia - Journal of Science and Medicine in Sport https://t.co/cXPmyWaBGy

[Dr Jessamy Tiffen @JessTiffen]

FDA approves first tumour-infiltrating lymphocyte (TIL) therapy, bolstering hopes for cell therapies in solid cancers https://t.co/V7OqHlm0wg